Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
Advertisement
The Scientist
Most Recent
Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.
Tailoring ethical oversight to participant-led research
Drosophila insulin-like peptides (dILPs) regulate part of the signaling pathway that helps keep organs growing in proportion during development.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Contributors
| March 1, 2013
Meet some of the people featured in the March 2013 issue of The Scientist.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
During development, communication between organs determines their relative final size.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
